Wells Fargo Sees Solid Outlook for MAA Despite Price Target Cut
Amgen Inc. (NASDAQ:AMGN) is included among the 15 Blue Chip Dividend Stocks to Build a Passive Income Porfolio.
On December 3, BMO Capital’s Evan Seigerman increased the firm’s price target on Amgen Inc. (NASDAQ:AMGN) to $372 from $335 and reiterated an Outperform rating. The analyst noted that the data from the Maritide Phase 2 Part 2 study could support further share gains beyond Amgen’s commercial performance in 2025. This update is considered the most important clinical milestone remaining for the company next year and may help clarify MariTide’s potential as a maintenance treatment.
BMO said the higher price target reflects a greater assumed profitability of success for MariTide and the benefits Amgen has gained from a more favorable macro environment.
Amgen Inc. (NASDAQ:AMGN) total revenue rose 12% YoY to $9.6 billion in the recent quarter. Several major medicines, including Repatha, which lowers harmful cholesterol levels, and the asthma therapy Tezspire, delivered strong results in the period. The company also continues to advance a robust pipeline that is expected to support new product approvals in the coming years.
Amgen Inc. (NASDAQ:AMGN)’s cash position also remained healthy. The company generated $4.2 billion in free cash flow during the third quarter of 2025, compared with $3.3 billion in the same quarter of 2024. The improvement was supported by working capital timing and lower interest expenses, partially offset by increased capital spending. The company has also raised its dividends for 14 years in a row.
Amgen Inc. (NASDAQ:AMGN) is a biotechnology company that discovers, develops, manufactures, and supplies innovative treatments for serious medical conditions.
While we acknowledge the potential of AMGN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 High Quality Dividend Stocks for Long-Term Investorsand 15 Dividend Stocks That Outperform the S&P 500
Disclosure: None.
Content Original Link:
" target="_blank">
